Showing 11 authorised medicines
Medicine Active substance Licence holder Status
Miramel 0.18 mg tablets PA0126/173/002
Pramipexole
Clonmel Healthcare Ltd
Marketed
Oprymea 0.088 mg tablets EU/1/08/469/1-5
Pramipexole
KRKA, d.d., Novo mesto
—
Oprymea 0.18 mg tablets EU/1/08/469/6-10
Pramipexole
KRKA, d.d., Novo mesto
—
Oprymea 0.26 mg prolonged-release tablets EU/1/08/469/026-029
Pramipexole
KRKA, d.d., Novo mesto
—
Oprymea 0.35 mg tablets EU/1/08/469/11-15
Pramipexole
KRKA, d.d., Novo mesto
—
Oprymea 0.52 mg prolonged-release tablets EU/1/08/469/030-033
Pramipexole
KRKA, d.d., Novo mesto
—
Oprymea 0.7 mg tablets EU/1/08/469/16-20
Pramipexole
KRKA, d.d., Novo mesto
—
Oprymea 1.05 mg prolonged-release tablets EU/1/08/469/034-037
Pramipexole
KRKA, d.d., Novo mesto
—
Oprymea 1.1 mg tablets EU/1/08/469/21-25
Pramipexole
KRKA, d.d., Novo mesto
—
Oprymea 1.57 mg prolonged-release tablets EU/1/08/469/038-041
Pramipexole
KRKA, d.d., Novo mesto
—
Oprymea 2.1 mg prolonged-release tablets EU/1/08/469/042-045
Pramipexole
KRKA, d.d., Novo mesto
—
Cite this database
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 6 July 2026).
Copy citation
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.